share_log

海普瑞:国投证券股份有限公司关于深圳市海普瑞药业集团股份有限公司子公司重要事项及收到监管关注函的临时受托管理事务报告

Haipuri: Report of SDIC Securities Co., Ltd. on important matters of the subsidiary of Shenzhen Haipuri Pharmaceutical Group Co., Ltd. and the receipt of a letter of regulatory concern

Sensex a share ·  Jan 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more